APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Leukocyte Surface Antigen CD47

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Leukocyte Surface Antigen CD47 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174007090322 December 2025182 pages

Choose your research edition.

Industry ResearchLeukocyte Surface Antigen CD47 Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Leukocyte Surface Antigen CD47 Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Leukocyte Surface Antigen CD47 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Leukocyte Surface Antigen CD47 Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Leukocyte Surface Antigen CD47 Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Leukocyte Surface Antigen CD47 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Leukocyte Surface Antigen CD47 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Leukocyte Surface Antigen CD47 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Leukocyte Surface Antigen CD47 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Leukocyte Surface Antigen CD47 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Leukocyte Surface Antigen CD47 include Trillium Therapeutics Inc, Surface Oncology Inc, Forty Seven Inc, Celgene Corp and Aurigene Discovery Technologies Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Leukocyte Surface Antigen CD47 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Leukocyte Surface Antigen CD47 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Leukocyte Surface Antigen CD47 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Leukocyte Surface Antigen CD47 market size, projected growth trends, production technologies, key applications, and end-use industries.

Leukocyte Surface Antigen CD47 Segment by Company

Trillium Therapeutics Inc

Surface Oncology Inc

Forty Seven Inc

Celgene Corp

Aurigene Discovery Technologies Ltd

Leukocyte Surface Antigen CD47 Segment by Type

PSTx-23

CC-90002

B-6H12

ALX-148

Others

Leukocyte Surface Antigen CD47 Segment by Application

Ischemia Reperfusion Injury

Kindney Transplant Rejection

Ovarian Cancer

Lymphoma

Others

Leukocyte Surface Antigen CD47 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Leukocyte Surface Antigen CD47 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Leukocyte Surface Antigen CD47 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Leukocyte Surface Antigen CD47.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Leukocyte Surface Antigen CD47 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Leukocyte Surface Antigen CD47 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Leukocyte Surface Antigen CD47 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Leukocyte Surface Antigen CD47 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Leukocyte Surface Antigen CD47 Industry Trends Table 2. Leukocyte Surface Antigen CD47 Industry Drivers Table 3. Leukocyte Surface Antigen CD47 Industry Opportunities and Challenges Table 4. Leukocyte Surface Antigen CD47 Industry Restraints Table 5. Global Leukocyte Surface Antigen CD47 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Leukocyte Surface Antigen CD47 Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Leukocyte Surface Antigen CD47 Sales Market Share by Manufacturers Table 9. Global Leukocyte Surface Antigen CD47 Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Leukocyte Surface Antigen CD47 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Leukocyte Surface Antigen CD47 Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Leukocyte Surface Antigen CD47 Manufacturers, Product Type & Application Table 13. Global Leukocyte Surface Antigen CD47 Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Leukocyte Surface Antigen CD47 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of PSTx-23 Table 17. Major Manufacturers of CC-90002 Table 18. Major Manufacturers of B-6H12 Table 19. Major Manufacturers of ALX-148 Table 20. Major Manufacturers of Others Table 21. Global Leukocyte Surface Antigen CD47 Sales by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Leukocyte Surface Antigen CD47 Sales by Type (2021-2026) & (k units) Table 23. Global Leukocyte Surface Antigen CD47 Sales by Type (2027-2032) & (k units) Table 24. Global Leukocyte Surface Antigen CD47 Sales Market Share by Type (2021-2026) Table 25. Global Leukocyte Surface Antigen CD47 Sales Market Share by Type (2027-2032) Table 26. Global Leukocyte Surface Antigen CD47 Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global Leukocyte Surface Antigen CD47 Revenue by Type (2021-2026) & (k units) Table 28. Global Leukocyte Surface Antigen CD47 Revenue by Type (2027-2032) & (k units) Table 29. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Type (2021-2026) Table 30. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Ischemia Reperfusion Injury Table 32. Major Manufacturers of Kindney Transplant Rejection Table 33. Major Manufacturers of Ovarian Cancer Table 34. Major Manufacturers of Lymphoma Table 35. Major Manufacturers of Others Table 36. Global Leukocyte Surface Antigen CD47 Sales by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Leukocyte Surface Antigen CD47 Sales by Application (2021-2026) & (k units) Table 38. Global Leukocyte Surface Antigen CD47 Sales by Application (2027-2032) & (k units) Table 39. Global Leukocyte Surface Antigen CD47 Sales Market Share by Application (2021-2026) Table 40. Global Leukocyte Surface Antigen CD47 Sales Market Share by Application (2027-2032) Table 41. Global Leukocyte Surface Antigen CD47 Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 42. Global Leukocyte Surface Antigen CD47 Revenue by Application (2021-2026) & (k units) Table 43. Global Leukocyte Surface Antigen CD47 Revenue by Application (2027-2032) & (k units) Table 44. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2021-2026) Table 45. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2027-2032) Table 46. Global Leukocyte Surface Antigen CD47 Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 47. Global Leukocyte Surface Antigen CD47 Sales by Region (2021-2026) & (k units) Table 48. Global Leukocyte Surface Antigen CD47 Sales Market Share by Region (2021-2026) Table 49. Global Leukocyte Surface Antigen CD47 Sales Forecasted by Region (2027-2032) & (k units) Table 50. Global Leukocyte Surface Antigen CD47 Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Leukocyte Surface Antigen CD47 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. North America Leukocyte Surface Antigen CD47 Sales by Country (2021-2026) & (k units) Table 53. North America Leukocyte Surface Antigen CD47 Sales by Country (2027-2032) & (k units) Table 54. Europe Leukocyte Surface Antigen CD47 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Europe Leukocyte Surface Antigen CD47 Sales by Country (2021-2026) & (k units) Table 56. Europe Leukocyte Surface Antigen CD47 Sales by Country (2027-2032) & (k units) Table 57. Asia Pacific Leukocyte Surface Antigen CD47 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Asia Pacific Leukocyte Surface Antigen CD47 Sales by Country (2021-2026) & (k units) Table 59. Asia Pacific Leukocyte Surface Antigen CD47 Sales by Country (2027-2032) & (k units) Table 60. South America, Middle East and Africa Leukocyte Surface Antigen CD47 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 61. South America, Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Country (2021-2026) & (k units) Table 62. South America, Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Country (2027-2032) & (k units) Table 63. Global Leukocyte Surface Antigen CD47 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Leukocyte Surface Antigen CD47 Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Leukocyte Surface Antigen CD47 Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Region (2021-2026) Table 67. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Region (2027-2032) Table 68. Trillium Therapeutics Inc Company Information Table 69. Trillium Therapeutics Inc Business Overview Table 70. Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Product Portfolio Table 72. Trillium Therapeutics Inc Recent Development Table 73. Surface Oncology Inc Company Information Table 74. Surface Oncology Inc Business Overview Table 75. Surface Oncology Inc Leukocyte Surface Antigen CD47 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Surface Oncology Inc Leukocyte Surface Antigen CD47 Product Portfolio Table 77. Surface Oncology Inc Recent Development Table 78. Forty Seven Inc Company Information Table 79. Forty Seven Inc Business Overview Table 80. Forty Seven Inc Leukocyte Surface Antigen CD47 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Forty Seven Inc Leukocyte Surface Antigen CD47 Product Portfolio Table 82. Forty Seven Inc Recent Development Table 83. Celgene Corp Company Information Table 84. Celgene Corp Business Overview Table 85. Celgene Corp Leukocyte Surface Antigen CD47 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Celgene Corp Leukocyte Surface Antigen CD47 Product Portfolio Table 87. Celgene Corp Recent Development Table 88. Aurigene Discovery Technologies Ltd Company Information Table 89. Aurigene Discovery Technologies Ltd Business Overview Table 90. Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Product Portfolio Table 92. Aurigene Discovery Technologies Ltd Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Leukocyte Surface Antigen CD47 Distributors List Table 96. Leukocyte Surface Antigen CD47 Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Leukocyte Surface Antigen CD47 Product Image Figure 2. Global Leukocyte Surface Antigen CD47 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Leukocyte Surface Antigen CD47 Market Size (2021-2032) & (US$ Million) Figure 4. Global Leukocyte Surface Antigen CD47 Sales (2021-2032) & (k units) Figure 5. Global Leukocyte Surface Antigen CD47 Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Leukocyte Surface Antigen CD47 Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. PSTx-23 Image Figure 9. CC-90002 Image Figure 10. B-6H12 Image Figure 11. ALX-148 Image Figure 12. Others Image Figure 13. Global Leukocyte Surface Antigen CD47 Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Leukocyte Surface Antigen CD47 Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Leukocyte Surface Antigen CD47 Sales Market Share by Type (2021-2032) Figure 16. Global Leukocyte Surface Antigen CD47 Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Leukocyte Surface Antigen CD47 Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Type (2021-2032) Figure 19. Ischemia Reperfusion Injury Image Figure 20. Kindney Transplant Rejection Image Figure 21. Ovarian Cancer Image Figure 22. Lymphoma Image Figure 23. Others Image Figure 24. Global Leukocyte Surface Antigen CD47 Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Leukocyte Surface Antigen CD47 Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Leukocyte Surface Antigen CD47 Sales Market Share by Application (2021-2032) Figure 27. Global Leukocyte Surface Antigen CD47 Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 28. Global Leukocyte Surface Antigen CD47 Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2021-2032) Figure 30. North America Leukocyte Surface Antigen CD47 Sales and Growth Rate (2021-2032) & (k units) Figure 31. North America Leukocyte Surface Antigen CD47 Sales Market Share by Country (2021-2032) Figure 32. U.S. Leukocyte Surface Antigen CD47 Sales and Growth Rate (2021-2032) & (k units) Figure 33. Canada Leukocyte Surface Antigen CD47 Sales and Growth Rate (2021-2032) & (k units) Figure 34. Mexico Leukocyte Surface Antigen CD47 Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Leukocyte Surface Antigen CD47 Sales and Growth Rate (2021-2032) & (k units) Figure 36. Europe Leukocyte Surface Antigen CD47 Sales Market Share by Country (2021-2032) Figure 37. Germany Leukocyte Surface Antigen CD47 Sales and Growth Rate (2021-2032) & (k units) Figure 38. France Leukocyte Surface Antigen CD47 Sales and Growth Rate (2021-2032) & (k units) Figure 39. U.K. Leukocyte Surface Antigen CD47 Sales and Growth Rate (2021-2032) & (k units) Figure 40. Italy Leukocyte Surface Antigen CD47 Sales and Growth Rate (2021-2032) & (k units) Figure 41. Netherlands Leukocyte Surface Antigen CD47 Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Leukocyte Surface Antigen CD47 Sales and Growth Rate (2021-2032) & (k units) Figure 43. Asia Pacific Leukocyte Surface Antigen CD47 Sales Market Share by Country (2021-2032) Figure 44. China Leukocyte Surface Antigen CD47 Sales and Growth Rate (2021-2032) & (k units) Figure 45. Japan Leukocyte Surface Antigen CD47 Sales and Growth Rate (2021-2032) & (k units) Figure 46. South Korea Leukocyte Surface Antigen CD47 Sales and Growth Rate (2021-2032) & (k units) Figure 47. Southeast Asia Leukocyte Surface Antigen CD47 Sales and Growth Rate (2021-2032) & (k units) Figure 48. India Leukocyte Surface Antigen CD47 Sales and Growth Rate (2021-2032) & (k units) Figure 49. Australia Leukocyte Surface Antigen CD47 Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Leukocyte Surface Antigen CD47 Sales and Growth Rate (2021-2032) & (k units) Figure 51. South America, Middle East and Africa Leukocyte Surface Antigen CD47 Sales Market Share by Country (2021-2032) Figure 52. Brazil Leukocyte Surface Antigen CD47 Sales and Growth Rate (2021-2032) & (k units) Figure 53. South Africa Leukocyte Surface Antigen CD47 Sales and Growth Rate (2021-2032) & (k units) Figure 54. Saudi Arabia Leukocyte Surface Antigen CD47 Sales and Growth Rate (2021-2032) & (k units) Figure 55. Turkey Leukocyte Surface Antigen CD47 Sales and Growth Rate (2021-2032) & (k units) Figure 56. Argentina Leukocyte Surface Antigen CD47 Sales and Growth Rate (2021-2032) & (k units) Figure 57. UAE Leukocyte Surface Antigen CD47 Sales and Growth Rate (2021-2032) & (k units) Figure 58. Egypt Leukocyte Surface Antigen CD47 Sales and Growth Rate (2021-2032) & (k units) Figure 59. Chile Leukocyte Surface Antigen CD47 Sales and Growth Rate (2021-2032) & (k units) Figure 60. Global Leukocyte Surface Antigen CD47 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Leukocyte Surface Antigen CD47 Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Figure 63. North America Leukocyte Surface Antigen CD47 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Figure 65. Europe Leukocyte Surface Antigen CD47 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Leukocyte Surface Antigen CD47 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Leukocyte Surface Antigen CD47 Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Leukocyte Surface Antigen CD47 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Leukocyte Surface Antigen CD47 Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Leukocyte Surface Antigen CD47 Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • PSTx-23
  • CC-90002
  • B-6H12
  • ALX-148
  • Others
Applications
  • Ischemia Reperfusion Injury
  • Kindney Transplant Rejection
  • Ovarian Cancer
  • Lymphoma
  • Others
Companies covered
  • Trillium Therapeutics Inc
  • Surface Oncology Inc
  • Forty Seven Inc
  • Celgene Corp
  • Aurigene Discovery Technologies Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Leukocyte Surface Antigen CD47 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Leukocyte Surface Antigen CD47 Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Leukocyte Surface Antigen CD47 Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Leukocyte Surface Antigen CD47 Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Leukocyte Surface Antigen CD47 Market Dynamics
  1. 2.1 Leukocyte Surface Antigen CD47 Industry Trends
  2. 2.2 Leukocyte Surface Antigen CD47 Industry Drivers
  3. 2.3 Leukocyte Surface Antigen CD47 Industry Opportunities and Challenges
  4. 2.4 Leukocyte Surface Antigen CD47 Industry Restraints
3 Leukocyte Surface Antigen CD47 Market by Manufacturers
  1. 3.1 Global Leukocyte Surface Antigen CD47 Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Leukocyte Surface Antigen CD47 Sales by Manufacturers (2021-2026)
  3. 3.3 Global Leukocyte Surface Antigen CD47 Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Leukocyte Surface Antigen CD47 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Leukocyte Surface Antigen CD47 Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Leukocyte Surface Antigen CD47 Manufacturers, Product Type & Application
  7. 3.7 Global Leukocyte Surface Antigen CD47 Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Leukocyte Surface Antigen CD47 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Leukocyte Surface Antigen CD47 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Leukocyte Surface Antigen CD47 Tier 1, Tier 2, and Tier 3
4 Leukocyte Surface Antigen CD47 Market by Type
  1. 4.1 Leukocyte Surface Antigen CD47 Type Introduction
  2. 4.1.1 PSTx-23
  3. 4.1.2 CC-90002
  4. 4.1.3 B-6H12
  5. 4.1.4 ALX-148
  6. 4.1.5 Others
  7. 4.2 Global Leukocyte Surface Antigen CD47 Sales by Type
  8. 4.2.1 Global Leukocyte Surface Antigen CD47 Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Leukocyte Surface Antigen CD47 Sales by Type (2021-2032)
  10. 4.2.3 Global Leukocyte Surface Antigen CD47 Sales Market Share by Type (2021-2032)
  11. 4.3 Global Leukocyte Surface Antigen CD47 Revenue by Type
  12. 4.3.1 Global Leukocyte Surface Antigen CD47 Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Leukocyte Surface Antigen CD47 Revenue by Type (2021-2032)
  14. 4.3.3 Global Leukocyte Surface Antigen CD47 Revenue Market Share by Type (2021-2032)
5 Leukocyte Surface Antigen CD47 Market by Application
  1. 5.1 Leukocyte Surface Antigen CD47 Application Introduction
  2. 5.1.1 Ischemia Reperfusion Injury
  3. 5.1.2 Kindney Transplant Rejection
  4. 5.1.3 Ovarian Cancer
  5. 5.1.4 Lymphoma
  6. 5.1.5 Others
  7. 5.2 Global Leukocyte Surface Antigen CD47 Sales by Application
  8. 5.2.1 Global Leukocyte Surface Antigen CD47 Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Leukocyte Surface Antigen CD47 Sales by Application (2021-2032)
  10. 5.2.3 Global Leukocyte Surface Antigen CD47 Sales Market Share by Application (2021-2032)
  11. 5.3 Global Leukocyte Surface Antigen CD47 Revenue by Application
  12. 5.3.1 Global Leukocyte Surface Antigen CD47 Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Leukocyte Surface Antigen CD47 Revenue by Application (2021-2032)
  14. 5.3.3 Global Leukocyte Surface Antigen CD47 Revenue Market Share by Application (2021-2032)
6 Global Leukocyte Surface Antigen CD47 Sales by Region
  1. 6.1 Global Leukocyte Surface Antigen CD47 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Leukocyte Surface Antigen CD47 Sales by Region (2021-2032)
  3. 6.2.1 Global Leukocyte Surface Antigen CD47 Sales by Region (2021-2026)
  4. 6.2.2 Global Leukocyte Surface Antigen CD47 Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Leukocyte Surface Antigen CD47 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Leukocyte Surface Antigen CD47 Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Leukocyte Surface Antigen CD47 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Leukocyte Surface Antigen CD47 Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Leukocyte Surface Antigen CD47 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Leukocyte Surface Antigen CD47 Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Leukocyte Surface Antigen CD47 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Leukocyte Surface Antigen CD47 Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Leukocyte Surface Antigen CD47 Revenue by Region
  1. 7.1 Global Leukocyte Surface Antigen CD47 Revenue by Region
  2. 7.1.1 Global Leukocyte Surface Antigen CD47 Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Leukocyte Surface Antigen CD47 Revenue by Region (2021-2026)
  4. 7.1.3 Global Leukocyte Surface Antigen CD47 Revenue by Region (2027-2032)
  5. 7.1.4 Global Leukocyte Surface Antigen CD47 Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Leukocyte Surface Antigen CD47 Revenue (2021-2032)
  8. 7.2.2 North America Leukocyte Surface Antigen CD47 Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Leukocyte Surface Antigen CD47 Revenue (2021-2032)
  11. 7.3.2 Europe Leukocyte Surface Antigen CD47 Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Leukocyte Surface Antigen CD47 Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Leukocyte Surface Antigen CD47 Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Leukocyte Surface Antigen CD47 Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Leukocyte Surface Antigen CD47 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Trillium Therapeutics Inc
  2. 8.1.1 Trillium Therapeutics Inc Company Information
  3. 8.1.2 Trillium Therapeutics Inc Business Overview
  4. 8.1.3 Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Trillium Therapeutics Inc Leukocyte Surface Antigen CD47 Product Portfolio
  6. 8.1.5 Trillium Therapeutics Inc Recent Developments
  7. 8.2 Surface Oncology Inc
  8. 8.2.1 Surface Oncology Inc Company Information
  9. 8.2.2 Surface Oncology Inc Business Overview
  10. 8.2.3 Surface Oncology Inc Leukocyte Surface Antigen CD47 Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Surface Oncology Inc Leukocyte Surface Antigen CD47 Product Portfolio
  12. 8.2.5 Surface Oncology Inc Recent Developments
  13. 8.3 Forty Seven Inc
  14. 8.3.1 Forty Seven Inc Company Information
  15. 8.3.2 Forty Seven Inc Business Overview
  16. 8.3.3 Forty Seven Inc Leukocyte Surface Antigen CD47 Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Forty Seven Inc Leukocyte Surface Antigen CD47 Product Portfolio
  18. 8.3.5 Forty Seven Inc Recent Developments
  19. 8.4 Celgene Corp
  20. 8.4.1 Celgene Corp Company Information
  21. 8.4.2 Celgene Corp Business Overview
  22. 8.4.3 Celgene Corp Leukocyte Surface Antigen CD47 Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Celgene Corp Leukocyte Surface Antigen CD47 Product Portfolio
  24. 8.4.5 Celgene Corp Recent Developments
  25. 8.5 Aurigene Discovery Technologies Ltd
  26. 8.5.1 Aurigene Discovery Technologies Ltd Company Information
  27. 8.5.2 Aurigene Discovery Technologies Ltd Business Overview
  28. 8.5.3 Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Aurigene Discovery Technologies Ltd Leukocyte Surface Antigen CD47 Product Portfolio
  30. 8.5.5 Aurigene Discovery Technologies Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Leukocyte Surface Antigen CD47 Value Chain Analysis
  2. 9.1.1 Leukocyte Surface Antigen CD47 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Leukocyte Surface Antigen CD47 Production Mode & Process
  6. 9.2 Leukocyte Surface Antigen CD47 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Leukocyte Surface Antigen CD47 Distributors
  9. 9.2.3 Leukocyte Surface Antigen CD47 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst